The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective evaluation of Middle Eastern patients (pts) with type II diabetes mellitus (DM) and colorectal cancer (CRC): Validation of metformin effect on overall survival (OS).
Amal Al Omari
No relevant relationships to disclose
Hadeel Abdelkaleq
No relevant relationships to disclose
Maysa Al-Hussaini
No relevant relationships to disclose
Rim Turfa
No relevant relationships to disclose
Nour Awad
No relevant relationships to disclose
Salwan S. Al Mutar
No relevant relationships to disclose
Hesham M. Hassabo
No relevant relationships to disclose
Ibrahim Halil Sahin
No relevant relationships to disclose
Manal Hassan
No relevant relationships to disclose
Chris R. Garrett
No relevant relationships to disclose